Urinalysis Market
完整報告名稱與涵蓋範圍
Urinalysis Market by Product (Consumables [Disposable, Reagents],Instruments [Automated, Microscopy, PoC]), Test Type (Pregnancy, Sediment), Application (UTI, Diabetes, CKD), Technology (Biochemical), End User (Hospital) & Region -Global Forecast to 2031
報告摘要
The urinalysis market is valued at around USD 4.88 billion in 2026 and is expected to reach USD 7.16 billion by 2031, reflecting an 8.0% growth rate. The rapid expansion of the elderly population is contributing to a higher incidence of age-related conditions, including diabetes and kidney and liver disorders. The increasing burden of these diseases is driving demand for routine diagnostic and monitoring tests, including metabolic, lipid, and renal and liver function assessments. Urinalysis analyzers play an important role in screening and monitoring several such conditions, thereby supporting their adoption across hospitals, diagnostic laboratories, and other healthcare settings. Consequently, the growing geriatric population and associated disease burden are expected to remain significant drivers of urinalysis market growth.
“Consumables accounted for the largest share in the urinalysis market, by product, in 2025.”
By product, the urinalysis market is segmented into consumables and instruments. The consumables segment accounts for the largest share of the urinalysis market. Recurring requirements and frequent replacement of consumables such as test strips, reagents, and controls are key drivers of its dominant share. Additionally, the availability of a wide range of consumables that cater to diverse urinalysis testing needs contributes to their widespread adoption. The development of advanced dipsticks with multiple test parameters further supports demand for urinalysis consumables.
“The biochemical assay segment accounted for the largest share in the urinalysis market, by technology, in 2025.”
By technology, the urinalysis market is segmented into biochemical assays, flow cytometry, digital microscopy, and other technologies. In 2025, the biochemical assay segment led the urinalysis market. This segment's significant share is largely driven by the widespread use of reagent strips and immunoassay-based testing for routine disease screening, point-of-care diagnosis, home-based pregnancy and fertility testing, and preliminary detection of urinary tract infections, kidney diseases, diabetes, and liver diseases. Moreover, the low cost and ease of use of biochemical assays, their broad applicability across hospitals, diagnostic laboratories, and home care settings, the rising burden of chronic and infectious diseases requiring frequent urine testing, and continuous product innovation by key players in reagent strip and immunoassay formats are further contributing to the growth of this segment.
“Asia Pacific: Fastest-growing region in the urinalysis market.”
The global urinalysis market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and the GCC countries. Asia Pacific is the fastest-growing regional market. This growth is driven by increasing government initiatives that promote disease awareness and early detection, rising per capita income, and the expansion of private healthcare infrastructure into rural and underserved areas. Additionally, the presence of emerging and high-growth markets across the region supports the adoption of urinalysis testing and diagnostic technologies.
The breakup of the profile of primary participants in the urinalysis market:
• By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (30%)
• By Designation: C-level Executives (27%), Directors (18%), and Other Designations (55%)
• By Region: North America (51%), Europe (21%), Asia Pacific (18%), Latin America (6%), and the Middle East & Africa (4%)
The key players in the urinalysis market are Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Cardinal Health (US), Sysmex Corporation (Japan), Thermo Fisher Scientific, Inc.(US), Danaher Corporation (US), Abbott (US), Bio-Rad Laboratories, Inc. (US), QuidelOrtho Corporation (Japan), Waters Corporation (US), Arkray, Inc. (Japan), Acon Laboratories, Inc. (US), 77 Elektronika KFT (Hungary), URIT Medical Electronic Group Co. Ltd. (China), Shenzhen, Mindray Bio-Medical Electronics Co., Ltd. (China), DIRUI Industrial Co. Ltd. (China), Biobase Group (China), ERBA Mannheim (UK), Alphatech Scientific (Peru), Teco Diagnostics (US), Analyticon Biotechnologies GmbH (Germany), Hivis Medical Technology Co., Ltd. (China), High Technology Inc. (US), Agappe Diagnostic Ltd. (India), Dialab GmbH (Austria), Quantimetrix (US), Biocare Corporation (Taiwan), Randox Laboratories Ltd. (Ireland), PZ Cormay S.A. (Poland), YD Diagnostics (South Korea), Contec Medical Systems Co., Ltd. (China), and Clarity Diagnostics LLC (US).
Research Coverage:
The scope of the report covers detailed information on the major factors, such as drivers, restraints, opportunities, and challenges, that influence the growth of the urinalysis market. A detailed analysis of key industry players has been conducted to provide insights into their business overviews, solutions, key strategies, acquisitions, and agreements. The report also covers new product launches and recent developments associated with the urinalysis market. Competitive analysis of upcoming startups in the urinalysis market ecosystem is included in this report.
Reasons to Buy this Report:
The report will assist market leaders and new entrants in the urinalysis industry by providing estimated revenue figures for the overall market and its subsegments. It aims to help stakeholders understand the competitive landscape, enabling them to position their businesses more effectively and develop appropriate go-to-market strategies. Additionally, the report offers insights into market dynamics, including key drivers, restraints, opportunities, and challenges.
The report provides insights into the following pointers:
• Analysis of key drivers (increasing burden of UTIs, diabetes, liver & kidney diseases, and bladder cancer, rising geriatric population and subsequent increase in age-associated diseases, and increasing adoption of PoC urine diagnostic tests), opportunities (growth opportunities in emerging countries, technological advancements in urine analyzers, and increasing government initiatives and funding for preventive care), restraints (availability of refurbished urine analyzers and high capital investments and lack of skilled laboratory technicians), and challenges (changing regulatory landscape) influencing the growth of the urinalysis market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the urinalysis market
• Market Development: Comprehensive information about lucrative markets; the report analyzes the urinalysis market across varied regions
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the urinalysis market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings of leading players like Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health (US), Abbott (US), and Danaher (US).
授權報價
| Single User Licence | $4,950 USD |
| Multi User Licence | $6,650 USD |
| Corporate User Licence | $8,150 USD |
| Global User Licence | $10,000 USD |
目錄 Table of Contents
1 INTRODUCTION 39
1.1 STUDY OBJECTIVES 39
1.2 MARKET DEFINITION 39
1.3 STUDY SCOPE 40
1.3.1 MARKETS COVERED AND REGIONAL SCOPE 40
1.3.2 INCLUSIONS AND EXCLUSIONS 41
1.3.3 YEARS CONSIDERED 42
1.4 CURRENCY CONSIDERED 42
1.5 STAKEHOLDERS 42
1.6 SUMMARY OF CHANGES 43
2 EXECUTIVE SUMMARY 44
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 44
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS 45
2.3 DISRUPTIVE TRENDS SHAPING MARKET 46
2.4 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS 47
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 48
3 PREMIUM INSIGHTS 49
3.1 URINALYSIS MARKET OVERVIEW 49
3.2 URINALYSIS MARKET, BY PRODUCT, 2026 VS. 2031 49
3.3 URINALYSIS MARKET, BY TEST TYPE, 2026 VS. 2031 50
3.4 URINALYSIS MARKET, BY APPLICATION, 2026 VS. 2031 50
3.5 URINALYSIS MARKET, BY TECHNOLOGY, 2026 VS. 2031 51
3.6 URINALYSIS MARKET, BY END USER, 2026 VS. 2031 51
3.7 URINALYSIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 52
4 MARKET OVERVIEW 53
4.1 INTRODUCTION 53
4.2 MARKET DYNAMICS 53
4.2.1 DRIVERS 54
4.2.1.1 Increasing burden of UTIs, diabetes, liver & kidney diseases, and bladder cancer 54
4.2.1.2 Rising geriatric population and subsequent increase in age-associated diseases 55
4.2.1.3 Increasing adoption of PoC urine diagnostic tests 56
4.2.2 RESTRAINTS 57
4.2.2.1 Availability of refurbished urine analyzers 57
4.2.2.2 High capital investments and lack of skilled laboratory technicians 57
4.2.3 OPPORTUNITIES 57
4.2.3.1 Growth opportunities in emerging countries 57
4.2.3.2 Technological advancements in urine analyzers 58
4.2.3.3 Increasing government initiatives and funding for preventive care 59
4.2.4 CHALLENGES 60
4.2.4.1 Changing regulatory landscape 60
4.3 UNMET NEEDS AND WHITE SPACES 60
4.3.1 UNMET NEEDS IN URINALYSIS DIAGNOSTICS MARKET 60
4.3.2 WHITE SPACE OPPORTUNITIES 61
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 62
4.4.1 INTERCONNECTED MARKETS 62
4.4.2 CROSS-SECTOR OPPORTUNITIES 63
4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS 64
4.5.1 KEY MOVES AND STRATEGIC FOCUS 64
5 INDUSTRY TRENDS 65
5.1 PORTER’S FIVE FORCES ANALYSIS 65
5.1.1 THREAT OF NEW ENTRANTS 66
5.1.2 THREAT OF SUBSTITUTES 66
5.1.3 BARGAINING POWER OF BUYERS 66
5.1.4 BARGAINING POWER OF SUPPLIERS 66
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 67
5.2 MACROECONOMIC INDICATORS 67
5.2.1 INTRODUCTION 67
5.2.2 GDP TRENDS AND FORECAST 67
5.3 SUPPLY CHAIN ANALYSIS 70
5.4 VALUE CHAIN ANALYSIS 71
5.5 ECOSYSTEM ANALYSIS 73
5.5.1 URINALYSIS MARKET: ROLE OF COMPANIES IN ECOSYSTEM 73
5.6 PRICING ANALYSIS 74
5.6.1 AVERAGE SELLING PRICE OF URINALYSIS, BY KEY PLAYER, 2024–2026 74
5.6.2 AVERAGE SELLING PRICE OF URINALYSIS BY REGION, 2024–2026 75
5.7 TRADE ANALYSIS 76
5.7.1 IMPORT SCENARIO (HS CODE 3822) 77
5.7.2 EXPORT SCENARIO (HS CODE 3822) 77
5.8 KEY CONFERENCES & EVENTS, 2026–2027 78
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 79
5.10 INVESTMENT & FUNDING SCENARIO 80
5.11 IMPACT OF 2025 US TARIFF ON URINALYSIS MARKET 80
5.11.1 INTRODUCTION 80
5.11.2 KEY TARIFF RATES 81
5.11.3 PRICE IMPACT ANALYSIS 81
5.11.4 IMPACT ON REGION 82
5.11.4.1 North America 82
5.11.4.2 Europe 82
5.11.4.3 Asia Pacific 82
5.11.5 IMPACT ON END-USE INDUSTRIES 83
5.11.5.1 Hospitals & Clinics 83
5.11.5.2 Home Care Settings 83
5.11.5.3 Diagnostic Laboratories 83
6 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 84
6.1 DECISION-MAKING PROCESS 84
6.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 84
6.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 84
6.2.2 BUYING CRITERIA 85
6.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 86
6.4 UNMET NEEDS IN VARIOUS END-USE INDUSTRIES 87
6.5 MARKET PROFITABILITY 89
6.5.1 REVENUE POTENTIAL 89
6.5.2 COST DYNAMICS 89
6.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS/INDUSTRIES 89
7 REGULATORY LANDSCAPE AND SUSTAINABILITY 91
7.1 REGIONAL REGULATIONS AND COMPLIANCE 91
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91
7.2 SUSTAINABILITY INITIATIVES 93
7.2.1 ENVIRONMENTAL IMPACT AND ECO-FRIENDLY INITIATIVES IN URINALYSIS 93
7.2.1.1 Eco-friendly Initiatives 94
7.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES 94
8 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 96
8.1 KEY EMERGING TECHNOLOGIES 96
8.1.1 AUTOMATED URINE ANALYZERS 96
8.1.2 BIOCHEMICAL ASSAY 97
8.2 COMPLEMENTARY TECHNOLOGIES 97
8.2.1 POINT-OF-CARE URINE ANALYZERS 97
8.3 ADJACENT TECHNOLOGIES 98
8.3.1 MULTIPLEX PCR 98
8.4 TECHNOLOGY/PRODUCT ROADMAP 98
8.5 PATENT ANALYSIS 100
8.5.1 LIST OF KEY PATENTS 101
8.6 FUTURE APPLICATIONS 102
8.7 IMPACT OF AI/GENERATIVE AI ON THE URINALYSIS MARKET 103
8.7.1 INTRODUCTION 103
8.7.2 TOP USE CASES AND MARKET POTENTIAL 104
8.7.3 KEY COMPANIES IMPLEMENTING AI 105
8.7.4 FUTURE OF AI/GEN AI 105
9 URINALYSIS MARKET, BY PRODUCT 106
9.1 INTRODUCTION 107
9.2 CONSUMABLES 107
9.2.1 PREGNANCY & FERTILITY KITS 111
9.2.1.1 Rapid accessibility and testing convenience to drive market 111
9.2.2 DIPSTICKS 114
9.2.2.1 Low cost to increase adoption 114
9.2.3 REAGENTS 118
9.2.3.1 Increasing use of controls and calibrators to drive market 118
9.2.4 DISPOSABLES 121
9.2.4.1 Wise usage in hospitals and clinical laboratories to support market growth 121
9.3 INSTRUMENTS 124
9.3.1 AUTOMATED URINE ANALYZERS 127
9.3.1.1 Integrated urine analyzers 131
9.3.1.1.1 Higher workload in hospitals and laboratories to increase adoption of integrated urine analyzers 131
9.3.1.2 Sediment urine analyzers 134
9.3.1.2.1 Microscopy analyzers 137
9.3.1.2.1.1 Increased speed and accuracy of analysis to drive adoption 137
9.3.1.2.2 Flow cytometry analyzers 140
9.3.1.2.2.1 Accuracy and sensitivity of flow cytometry analyzers to drive adoption 140
9.3.1.3 Biochemical urine analyzers 143
9.3.1.3.1 Increasing incidence of kidney diseases and UTIs to drive market 143
9.3.2 SEMI-AUTOMATED URINE ANALYZERS 146
9.3.2.1 Extensive use in hospitals & clinics to drive segment growth 146
9.3.3 POINT-OF-CARE URINE ANALYZERS 149
9.3.3.1 Need for rapid testing to drive demand for PoC urine analyzers 149
10 URINALYSIS MARKET, BY APPLICATION 153
10.1 INTRODUCTION 154
10.2 DISEASE SCREENING 154
10.2.1 URINARY TRACT INFECTIONS 157
10.2.1.1 Increasing prevalence of UTIs to drive segment growth 157
10.2.2 KIDNEY DISEASES 160
10.2.2.1 Rapidly growing geriatric population and increasing prevalence of kidney diseases to fuel segment growth 160
10.2.3 DIABETES 164
10.2.3.1 Development of advanced analytical tools to drive market 164
10.2.4 LIVER DISEASES 167
10.2.4.1 High prevalence of liver diseases to support market growth 167
10.2.5 OTHER DISEASE SCREENING APPLICATIONS 170
10.3 PREGNANCY & FERTILITY TESTING 173
10.3.1 NEED FOR EARLY DETECTION OF PREGNANCY TO DRIVE SEGMENT 173
11 URINALYSIS MARKET, BY TEST TYPE 176
11.1 INTRODUCTION 177
11.2 PREGNANCY & FERTILITY TESTS 177
11.2.1 RISING DEMAND FOR RAPID SELF-CONTAINED TESTS TO DRIVE MARKET 177
11.3 BIOCHEMICAL TESTS 180
11.3.1 LABORATORY TESTS 184
11.3.1.1 Growing incidence of UTIs and other kidney diseases to drive market 184
11.3.2 POC TESTS 187
11.3.2.1 Convenience of PoC testing to drive segment growth 187
11.4 SEDIMENT URINALYSIS 190
11.4.1 INCREASED ADOPTION OF AUTOMATED ANALYZERS TO DRIVE MARKET 190
12 URINALYSIS MARKET, BY TECHNOLOGY 193
12.1 INTRODUCTION 194
12.2 BIOCHEMICAL ASSAY 194
12.2.1 WIDESPREAD USE ACROSS DISEASE SCREENING AND HOME-BASED TESTING TO SUPPORT SEGMENT DOMINANCE 194
12.3 FLOW CYTOMETRY 197
12.3.1 RISING ADOPTION OF AUTOMATED SEDIMENT ANALYSIS TO DRIVE STEADY GROWTH 197
12.4 DIGITAL MICROSCOPY 199
12.4.1 GROWING PREFERENCE FOR AI-ASSISTED IMAGING TO ACCELERATE ADOPTION 199
12.5 OTHER TECHNOLOGIES 202
13 URINALYSIS MARKET, BY END USER 205
13.1 INTRODUCTION 206
13.2 DIAGNOSTIC LABORATORIES 206
13.2.1 INCREASED OUTSOURCING OF DIAGNOSTIC TESTS BY HOSPITALS TO LABORATORIES TO AUGMENT MARKET 206
13.3 HOSPITALS & CLINICS 209
13.3.1 GROWING NUMBER OF HOSPITALS WORLDWIDE TO BOOST GROWTH 209
13.4 HOME CARE SETTINGS 212
13.4.1 INCREASING PREFERENCE FOR RAPID TESTING AND CONVENIENCE TO BOOST MARKET 212
13.5 RESEARCH LABORATORIES & INSTITUTES 215
13.5.1 DEVELOPMENT OF INNOVATIVE TESTS FOR DISEASE DETECTION TO FUEL MARKET 215
14 URINALYSIS MARKET, BY REGION 219
14.1 INTRODUCTION 220
14.2 NORTH AMERICA 220
14.2.1 US 226
14.2.1.1 Rising prevalence of chronic diseases to drive market 226
14.2.2 CANADA 231
14.2.2.1 Rising burden of CKD to augment market 231
14.3 EUROPE 235
14.3.1 GERMANY 240
14.3.1.1 Increasing healthcare expenditure to fuel market growth 240
14.3.2 UK 245
14.3.2.1 Rising government healthcare expenditure to propel market 245
14.3.3 FRANCE 249
14.3.3.1 High R&D expenditure to provide growth opportunities 249
14.3.4 ITALY 253
14.3.4.1 Rising prevalence of diabetes to drive market 253
14.3.5 SPAIN 258
14.3.5.1 Growing elderly population to propel market 258
14.3.6 REST OF EUROPE 262
14.4 ASIA PACIFIC 266
14.4.1 CHINA 272
14.4.1.1 Improving healthcare infrastructure to support market growth 272
14.4.2 JAPAN 276
14.4.2.1 Favorable regulatory framework to drive market growth 276
14.4.3 INDIA 281
14.4.3.1 Increasing investments in healthcare system to drive market 281
14.4.4 AUSTRALIA 285
14.4.4.1 Rising prevalence of chronic diseases to propel market 285
14.4.5 SOUTH KOREA 289
14.4.5.1 Growing medical tourism to drive demand for urinalysis 289
14.4.6 REST OF ASIA PACIFIC 293
14.5 LATIN AMERICA 298
14.5.1 BRAZIL 303
14.5.1.1 Largest healthcare market in Latin America 303
14.5.2 MEXICO 307
14.5.2.1 Popularity in medical tourism to drive market growth 307
14.5.3 REST OF LATIN AMERICA 311
14.6 MIDDLE EAST & AFRICA 315
14.6.1 UAE 320
14.6.1.1 High diabetes prevalence to drive demand for urinalysis 320
14.6.2 SAUDI ARABIA 324
14.6.2.1 Rising diabetes burden to support market growth 324
14.6.3 REST OF MIDDLE EAST & AFRICA 328
15 COMPETITIVE LANDSCAPE 333
15.1 INTRODUCTION 333
15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 333
15.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN URINALYSIS MARKET 334
15.3 REVENUE ANALYSIS, 2023–2025 335
15.4 MARKET SHARE ANALYSIS, 2025 336
15.4.1 GLOBAL MARKET SHARE ANALYSIS, 2025 336
15.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 338
15.5.1 STARS 338
15.5.2 EMERGING LEADERS 338
15.5.3 PERVASIVE PLAYERS 338
15.5.4 PARTICIPANTS 339
15.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 340
15.5.5.1 Company footprint 340
15.5.5.2 Region footprint 340
15.5.5.3 Product footprint 341
15.5.5.4 Application footprint 341
15.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 342
15.6.1 PROGRESSIVE COMPANIES 342
15.6.2 RESPONSIVE COMPANIES 342
15.6.3 DYNAMIC COMPANIES 342
15.6.4 STARTING BLOCKS 342
15.6.5 COMPANY FOOTPRINT: STARTUPS/SMES, 2025 344
15.6.5.1 Detailed list of key startups/SMEs 344
15.6.5.2 Competitive benchmarking of startups/SMEs, by product and application 345
15.6.5.3 Competitive benchmarking of startups/SMEs, by region 345
15.7 COMPANY VALUATION & FINANCIAL METRICS 346
15.7.1 FINANCIAL METRICS 346
15.7.2 COMPANY VALUATION 346
15.8 BRAND/PRODUCT COMPARISON 347
15.9 COMPETITIVE SCENARIO 348
15.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS 348
15.9.2 DEALS 348
15.9.3 EXPANSIONS 350
16 COMPANY PROFILES 352
16.1 KEY PLAYERS 352
16.1.1 SIEMENS HEALTHINEERS AG 352
16.1.1.1 Business overview 352
16.1.1.2 Products offered 353
16.1.1.3 Recent developments 354
16.1.1.3.1 Product launches 354
16.1.1.3.2 Deals 355
16.1.1.3.3 Expansions 356
16.1.1.4 MnM view 356
16.1.1.4.1 Key strengths 356
16.1.1.4.2 Strategic choices 357
16.1.1.4.3 Weaknesses & competitive threats 357
16.1.2 F. HOFFMANN-LA ROCHE LTD 358
16.1.2.1 Business overview 358
16.1.2.2 Products offered 359
16.1.2.3 MnM view 360
16.1.2.3.1 Key strengths 360
16.1.2.3.2 Strategic choices 360
16.1.2.3.3 Weaknesses & competitive threats 360
16.1.3 SYSMEX CORPORATION 361
16.1.3.1 Business overview 361
16.1.3.2 Products offered 362
16.1.3.3 Recent developments 363
16.1.3.3.1 Product launches 363
16.1.3.3.2 Expansions 363
16.1.3.4 MnM view 364
16.1.3.4.1 Key strengths 364
16.1.3.4.2 Strategic choices 364
16.1.3.4.3 Weaknesses & competitive threats 364
16.1.4 DANAHER CORPORATION 365
16.1.4.1 Business overview 365
16.1.4.2 Products offered 366
16.1.4.3 Recent developments 367
16.1.4.3.1 Product launches 367
16.1.4.3.2 Deals 367
16.1.4.4 MnM view 367
16.1.4.4.1 Key strengths 367
16.1.4.4.2 Strategic choices 367
16.1.4.4.3 Weaknesses & competitive threats 368
16.1.5 ABBOTT 369
16.1.5.1 Business overview 369
16.1.5.2 Products offered 370
16.1.5.3 MnM view 371
16.1.5.3.1 Key strengths 371
16.1.5.3.2 Strategic choices 371
16.1.5.3.3 Weaknesses & competitive threats 372
16.1.6 CARDINAL HEALTH, INC. 373
16.1.6.1 Business overview 373
16.1.6.2 Products offered 374
16.1.6.3 Recent developments 375
16.1.6.3.1 Expansions 375
16.1.7 WATERS CORPORATION 376
16.1.7.1 Business overview 376
16.1.7.2 Products offered 377
16.1.7.3 Recent developments 378
16.1.7.3.1 Deals 378
16.1.8 THERMO FISHER SCIENTIFIC INC. 379
16.1.8.1 Business overview 379
16.1.8.2 Products offered 380
16.1.9 BIO-RAD LABORATORIES, INC. 381
16.1.9.1 Business overview 381
16.1.9.2 Products offered 382
16.1.10 QUIDELORTHO CORPORATION 383
16.1.10.1 Business overview 383
16.1.10.2 Products offered 384
16.2 OTHER PLAYERS 385
16.2.1 ARKRAY, INC. 385
16.2.2 ACON LABORATORIES, INC. 386
16.2.3 77 ELEKTRONIKA KFT. 387
16.2.4 URIT MEDICAL ELECTRONIC CO., LTD. 388
16.2.5 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 389
16.2.6 DIRUI INDUSTRIAL CO., LTD. 390
16.2.7 BIOBASE GROUP 391
16.2.8 ERBA MANNHEIM 391
16.2.9 ALPHATEC SCIENTIFIC E.I.R.L. 392
16.2.10 TECO DIAGNOSTICS 393
16.2.11 ANALYTICON BIOTECHNOLOGIES GMBH 394
16.2.12 HIVIS MEDICAL TECHNOLOGY CO., LTD. 395
16.2.13 HIGH TECHNOLOGY, INC. 396
16.2.14 AGAPPE DIAGNOSTICS LTD 396
16.2.15 DIALAB GMBH 397
16.2.16 QUANTIMETRIX 397
16.2.17 BIOCARE CORPORATION 398
16.2.18 RANDOX LABORATORIES LTD. 398
16.2.19 PZ CORMAY S.A. 399
16.2.20 YD DIAGNOSTICS 400
16.2.21 CONTEC MEDICAL SYSTEMS CO., LTD. 400
16.2.22 CLARITY DIAGNOSTICS, LLC 401
16.2.23 BIOPANDA REAGENTS LTD. 402
16.2.24 GENUINE BIOSYSTEM 402
17 RESEARCH METHODOLOGY 403
17.1 RESEARCH DATA 403
17.2 RESEARCH APPROACH 403
17.2.1 SECONDARY DATA 404
17.2.1.1 Key data from secondary sources 404
17.2.2 PRIMARY DATA 405
17.2.2.1 List of primary sources 405
17.2.2.2 Key data from primary sources 406
17.2.2.3 Key industry insights 407
17.2.2.4 Breakdown of primary interviews 408
17.3 MARKET SIZE ESTIMATION 408
17.3.1 TOTAL MARKET SIZE: URINALYSIS MARKET 408
17.3.2 BOTTOM-UP APPROACH 408
17.3.2.1 Approach 1: Company revenue estimation approach 409
17.3.2.2 Approach 2: Presentations of companies and primary interviews 409
17.3.2.3 Growth forecast 409
17.3.2.4 CAGR projections 410
17.3.3 TOP-DOWN APPROACH 410
17.4 DATA TRIANGULATION 411
17.5 RESEARCH ASSUMPTIONS 413
17.5.1 STUDY-RELATED ASSUMPTIONS 413
17.6 STUDY ASSUMPTIONS 413
17.6.1 PARAMETRIC ASSUMPTIONS 414
17.6.2 GROWTH RATE ASSUMPTIONS 414
17.7 RESEARCH LIMITATIONS 414
17.8 RISK ASSESSMENT 415
18 APPENDIX 416
18.1 DISCUSSION GUIDE 416
18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 421
18.3 CUSTOMIZATION OPTIONS 423
18.4 RELATED REPORTS 423
18.5 AUTHOR DETAILS 424
圖表清單 List of Tables & Figures
TABLE 1 AGE-STANDARDIZED PREVALENCE OF DIABETES, % BY REGION, 2024 VS. 2050 55
TABLE 2 PERCENTAGE OF POPULATION AGED 65 YEARS OR OVER,
BY REGION, 2030 VS. 2050 56
TABLE 3 URINALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS 66
TABLE 4 GDP PERCENTAGE CHANGE (%), BY KEY COUNTRY, 2023–2030 67
TABLE 5 NORTH AMERICA: MACROECONOMIC INDICATORS 69
TABLE 6 EUROPE: MACROECONOMIC INDICATORS 69
TABLE 7 ASIA PACIFIC: MACROECONOMIC INDICATORS 69
TABLE 8 LATIN AMERICA: MACROECONOMIC INDICATORS 69
TABLE 9 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 70
TABLE 10 AVERAGE SELLING PRICE OF URINALYSIS PRODUCTS, BY KEY PLAYER, 2024–2026 (USD) 75
TABLE 11 AVERAGE SELLING PRICE OF URINALYSIS PRODUCTS, BY REGION,
2024–2026 (USD) 76
TABLE 12 IMPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD MILLION) 77
TABLE 13 EXPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD MILLION) 77
TABLE 14 URINALYSIS MARKET: KEY CONFERENCES AND EVENTS, 2026–2027 78
TABLE 15 US-ADJUSTED RECIPROCAL TARIFF RATES 81
TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT (%) 85
TABLE 17 KEY BUYING CRITERIA, BY PRODUCT 85
TABLE 18 ADOPTION BARRIERS & INTERNAL CHALLENGES 86
TABLE 19 URINALYSIS MARKET: UNMET NEEDS IN VARIOUS END-USE INDUSTRIES 88
TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91
TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91
TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92
TABLE 23 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92
TABLE 24 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 93
TABLE 25 KEY PATENTS IN URINALYSIS MARKET, 2023–2025 101
TABLE 26 KEY COMPANIES IMPLEMENTING AI IN URINALYSIS MARKET 105
TABLE 27 URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 107
TABLE 28 KEY PRODUCTS IN URINALYSIS CONSUMABLES MARKET 107
TABLE 29 URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 108
TABLE 30 URINALYSIS MARKET FOR CONSUMABLES, BY REGION, 2024–2031 (USD MILLION) 108
TABLE 31 NORTH AMERICA: URINALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 109
TABLE 32 EUROPE: URINALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 109
TABLE 33 ASIA PACIFIC: URINALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 110
TABLE 34 LATIN AMERICA: URINALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 110
TABLE 35 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 110
TABLE 36 KEY PRODUCTS IN PREGNANCY & FERTILITY KITS MARKET 111
TABLE 37 URINALYSIS MARKET FOR PREGNANCY & FERTILITY KITS, BY REGION, 2024–2031 (USD MILLION) 112
TABLE 38 NORTH AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY KITS, BY COUNTRY, 2024–2031 (USD MILLION) 112
TABLE 39 EUROPE: URINALYSIS MARKET FOR PREGNANCY & FERTILITY KITS, BY COUNTRY, 2024–2031 (USD MILLION) 113
TABLE 40 ASIA PACIFIC: URINALYSIS MARKET FOR PREGNANCY & FERTILITY KITS, BY COUNTRY, 2024–2031 (USD MILLION) 113
TABLE 41 LATIN AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY KITS, BY COUNTRY, 2024–2031 (USD MILLION) 114
TABLE 42 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY KITS, BY COUNTRY, 2024–2031 (USD MILLION) 114
TABLE 43 KEY PRODUCTS IN URINALYSIS DIPSTICKS/URINE TEST STRIPS MARKET 115
TABLE 44 URINALYSIS MARKET FOR DIPSTICKS, BY REGION, 2024–2031 (USD MILLION) 115
TABLE 45 NORTH AMERICA: URINALYSIS MARKET FOR DIPSTICKS CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 116
TABLE 46 EUROPE: URINALYSIS MARKET FOR DIPSTICKS, BY COUNTRY, 2024–2031 (USD MILLION) 116
TABLE 47 ASIA PACIFIC: URINALYSIS MARKET FOR DIPSTICKS, BY COUNTRY, 2024–2031 (USD MILLION) 117
TABLE 48 LATIN AMERICA: URINALYSIS MARKET FOR DIPSTICKS, BY COUNTRY, 2024–2031 (USD MILLION) 117
TABLE 49 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR DIPSTICKS, BY COUNTRY, 2024–2031 (USD MILLION) 118
TABLE 50 KEY PRODUCTS IN URINALYSIS REAGENTS MARKET 118
TABLE 51 URINALYSIS MARKET FOR REAGENTS, BY REGION, 2024–2031 (USD MILLION) 119
TABLE 52 NORTH AMERICA: URINALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 119
TABLE 53 EUROPE: URINALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 119
TABLE 54 ASIA PACIFIC: URINALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 120
TABLE 55 LATIN AMERICA: URINALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 120
TABLE 56 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 120
TABLE 57 URINALYSIS MARKET FOR DISPOSABLES, BY REGION, 2024–2031 (USD MILLION) 121
TABLE 58 NORTH AMERICA: URINALYSIS MARKET FOR DISPOSABLES, BY COUNTRY, 2024–2031 (USD MILLION) 122
TABLE 59 EUROPE: URINALYSIS MARKET FOR DISPOSABLES, BY COUNTRY, 2024–2031 (USD MILLION) 122
TABLE 60 ASIA PACIFIC: URINALYSIS MARKET FOR DISPOSABLES, BY COUNTRY, 2024–2031 (USD MILLION) 123
TABLE 61 LATIN AMERICA: URINALYSIS MARKET FOR DISPOSABLES, BY COUNTRY, 2024–2031 (USD MILLION) 123
TABLE 62 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR DISPOSABLES, BY COUNTRY, 2024–2031 (USD MILLION) 123
TABLE 63 KEY PRODUCTS IN URINALYSIS INSTRUMENTS MARKET 124
TABLE 64 URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 125
TABLE 65 URINALYSIS MARKET FOR INSTRUMENTS, BY REGION, 2024–2031 (USD MILLION) 125
TABLE 66 NORTH AMERICA: URINALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2024–2031 (USD MILLION) 125
TABLE 67 EUROPE: URINALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2024–2031 (USD MILLION) 126
TABLE 68 ASIA PACIFIC: URINALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2024–2031 (USD MILLION) 126
TABLE 69 LATIN AMERICA: URINALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2024–2031 (USD MILLION) 127
TABLE 70 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2024–2031 (USD MILLION) 127
TABLE 71 KEY PRODUCTS IN AUTOMATED URINE ANALYZERS MARKET 128
TABLE 72 AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 128
TABLE 73 URINALYSIS MARKET FOR AUTOMATED URINE ANALYZERS, BY REGION, 2024–2031 (USD MILLION) 128
TABLE 74 NORTH AMERICA: URINALYSIS MARKET FOR AUTOMATED URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 129
TABLE 75 EUROPE: URINALYSIS MARKET FOR AUTOMATED URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 129
TABLE 76 ASIA PACIFIC: URINALYSIS MARKET FOR AUTOMATED URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 130
TABLE 77 LATIN AMERICA: URINALYSIS MARKET FOR AUTOMATED URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 130
TABLE 78 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR AUTOMATED URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 130
TABLE 79 KEY PRODUCTS IN INTEGRATED URINE ANALYZERS MARKET 131
TABLE 80 URINALYSIS MARKET FOR INTEGRATED URINE ANALYZERS, BY REGION, 2024–2031 (USD MILLION) 131
TABLE 81 NORTH AMERICA: URINALYSIS MARKET FOR INTEGRATED URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 132
TABLE 82 EUROPE: URINALYSIS MARKET FOR INTEGRATED URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 132
TABLE 83 ASIA PACIFIC: URINALYSIS MARKET FOR INTEGRATED URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 133
TABLE 84 LATIN AMERICA: URINALYSIS MARKET FOR INTEGRATED URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 133
TABLE 85 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR INTEGRATED URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 134
TABLE 86 KEY PRODUCTS IN SEDIMENT URINE ANALYZERS MARKET 134
TABLE 87 SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 135
TABLE 88 URINALYSIS MARKET FOR SEDIMENT URINE ANALYZERS, BY REGION, 2024–2031 (USD MILLION) 135
TABLE 89 NORTH AMERICA: URINALYSIS MARKET FOR SEDIMENT URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 135
TABLE 90 EUROPE: URINALYSIS MARKET FOR SEDIMENT URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 136
TABLE 91 ASIA PACIFIC: URINALYSIS MARKET FOR SEDIMENT URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 136
TABLE 92 LATIN AMERICA: URINALYSIS MARKET FOR SEDIMENT URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 137
TABLE 93 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR SEDIMENT URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 137
TABLE 94 URINALYSIS MARKET FOR MICROSCOPY ANALYZERS, BY REGION, 2024–2031 (USD MILLION) 138
TABLE 95 NORTH AMERICA: URINALYSIS MARKET FOR MICROSCOPY ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 138
TABLE 96 EUROPE: URINALYSIS MARKET FOR MICROSCOPY ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 139
TABLE 97 ASIA PACIFIC: URINALYSIS MARKET FOR MICROSCOPY ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 139
TABLE 98 LATIN AMERICA: URINALYSIS MARKET FOR MICROSCOPY ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 140
TABLE 99 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR MICROSCOPY ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 140
TABLE 100 URINALYSIS MARKET FOR FLOW CYTOMETRY ANALYZERS, BY REGION, 2024–2031 (USD MILLION) 141
TABLE 101 NORTH AMERICA: URINALYSIS MARKET FOR FLOW CYTOMETRY ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 141
TABLE 102 EUROPE: URINALYSIS MARKET FOR FLOW CYTOMETRY ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 142
TABLE 103 ASIA PACIFIC: URINALYSIS MARKET FOR FLOW CYTOMETRY ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 142
TABLE 104 LATIN AMERICA: URINALYSIS MARKET FOR FLOW CYTOMETRY ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 143
TABLE 105 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR FLOW CYTOMETRY ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 143
TABLE 106 KEY PRODUCTS IN BIOCHEMICAL URINE ANALYZERS MARKET 144
TABLE 107 URINALYSIS MARKET FOR BIOCHEMICAL URINE ANALYZERS, BY REGION, 2024–2031 (USD MILLION) 144
TABLE 108 NORTH AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 144
TABLE 109 EUROPE: URINALYSIS MARKET FOR BIOCHEMICAL URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 145
TABLE 110 ASIA PACIFIC: URINALYSIS MARKET FOR BIOCHEMICAL URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 145
TABLE 111 LATIN AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 146
TABLE 112 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR BIOCHEMICAL URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 146
TABLE 113 KEY PRODUCTS IN SEMI-AUTOMATED URINE ANALYZERS MARKET 147
TABLE 114 URINALYSIS MARKET FOR SEMI-AUTOMATED URINE ANALYZERS, BY REGION, 2024–2031 (USD MILLION) 147
TABLE 115 NORTH AMERICA: URINALYSIS MARKET FOR SEMI-AUTOMATED URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 147
TABLE 116 EUROPE: URINALYSIS MARKET FOR SEMI-AUTOMATED URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 148
TABLE 117 ASIA PACIFIC: URINALYSIS MARKET FOR SEMI-AUTOMATED URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 148
TABLE 118 LATIN AMERICA: URINALYSIS MARKET FOR SEMI-AUTOMATED URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 149
TABLE 119 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR SEMI-AUTOMATED URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 149
TABLE 120 KEY PRODUCTS IN POINT-OF-CARE URINE ANALYZERS MARKET 150
TABLE 121 URINALYSIS MARKET FOR POINT-OF-CARE URINE ANALYZERS, BY REGION, 2024–2031 (USD MILLION) 150
TABLE 122 NORTH AMERICA: URINALYSIS MARKET FOR POINT-OF-CARE URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 150
TABLE 123 EUROPE: URINALYSIS MARKET FOR POINT-OF-CARE URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 151
TABLE 124 ASIA PACIFIC: URINALYSIS MARKET FOR POINT-OF-CARE URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 151
TABLE 125 LATIN AMERICA: URINALYSIS MARKET FOR POINT-OF-CARE URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 152
TABLE 126 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR POINT-OF-CARE URINE ANALYZERS, BY COUNTRY, 2024–2031 (USD MILLION) 152
TABLE 127 URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 154
TABLE 128 URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION) 155
TABLE 129 URINALYSIS MARKET FOR DISEASE SCREENING, BY REGION, 2024–2031 (USD MILLION) 155
TABLE 130 NORTH AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2024–2031 (USD MILLION) 155
TABLE 131 EUROPE: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2024–2031 (USD MILLION) 156
TABLE 132 ASIA PACIFIC: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2024–2031 (USD MILLION) 156
TABLE 133 LATIN AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2024–2031 (USD MILLION) 157
TABLE 134 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY COUNTRY, 2024–2031 (USD MILLION) 157
TABLE 135 URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY REGION, 2024–2031 (USD MILLION) 158
TABLE 136 NORTH AMERICA: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2024–2031 (USD MILLION) 158
TABLE 137 EUROPE: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2024–2031 (USD MILLION) 159
TABLE 138 ASIA PACIFIC: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2024–2031 (USD MILLION) 159
TABLE 139 LATIN AMERICA: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2024–2031 (USD MILLION) 160
TABLE 140 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2024–2031 (USD MILLION) 160
TABLE 141 TOTAL GERIATRIC POPULATION, 2030 VS. 2050 (%) 161
TABLE 142 URINALYSIS MARKET FOR KIDNEY DISEASES, BY REGION, 2024–2031 (USD MILLION) 162
TABLE 143 NORTH AMERICA: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2024–2031 (USD MILLION) 162
TABLE 144 EUROPE: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2024–2031 (USD MILLION) 162
TABLE 145 ASIA PACIFIC: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2024–2031 (USD MILLION) 163
TABLE 146 LATIN AMERICA: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2024–2031 (USD MILLION) 163
TABLE 147 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR KIDNEY DISEASES, BY COUNTRY, 2024–2031 (USD MILLION) 163
TABLE 148 ESTIMATED NUMBER OF PEOPLE WITH DIABETES, BY REGION, 2024 VS. 2050 (IN MILLION) 164
TABLE 149 URINALYSIS MARKET FOR DIABETES, BY REGION, 2024–2031 (USD MILLION) 164
TABLE 150 NORTH AMERICA: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2024–2031 (USD MILLION) 165
TABLE 151 EUROPE: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2024–2031 (USD MILLION) 165
TABLE 152 ASIA PACIFIC: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2024–2031 (USD MILLION) 166
TABLE 153 LATIN AMERICA: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2024–2031 (USD MILLION) 166
TABLE 154 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2024–2031 (USD MILLION) 166
TABLE 155 URINALYSIS MARKET FOR LIVER DISEASES, BY REGION, 2024–2031 (USD MILLION) 167
TABLE 156 NORTH AMERICA: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2024–2031 (USD MILLION) 168
TABLE 157 EUROPE: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2024–2031 (USD MILLION) 168
TABLE 158 ASIA PACIFIC: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2024–2031 (USD MILLION) 169
TABLE 159 LATIN AMERICA: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2024–2031 (USD MILLION) 169
TABLE 160 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR LIVER DISEASES, BY COUNTRY, 2024–2031 (USD MILLION) 169
TABLE 161 URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 170
TABLE 162 NORTH AMERICA: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 171
TABLE 163 EUROPE: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 171
TABLE 164 ASIA PACIFIC: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 172
TABLE 165 LATIN AMERICA: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 172
TABLE 166 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 172
TABLE 167 URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY REGION, 2024–2031 (USD MILLION) 173
TABLE 168 NORTH AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 174
TABLE 169 EUROPE: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 174
TABLE 170 ASIA PACIFIC: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 175
TABLE 171 LATIN AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 175
TABLE 172 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 175
TABLE 173 URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 177
TABLE 174 URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY REGION, 2024–2031 (USD MILLION) 178
TABLE 175 NORTH AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2024–2031 (USD MILLION) 178
TABLE 176 EUROPE: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2024–2031 (USD MILLION) 179
TABLE 177 ASIA PACIFIC: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2024–2031 (USD MILLION) 179
TABLE 178 LATIN AMERICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2024–2031 (USD MILLION) 180
TABLE 179 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY COUNTRY, 2024–2031 (USD MILLION) 180
TABLE 180 URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION) 181
TABLE 181 URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY REGION, 2024–2031 (USD MILLION) 181
TABLE 182 NORTH AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2024–2031 (USD MILLION) 182
TABLE 183 EUROPE: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2024–2031 (USD MILLION) 182
TABLE 184 ASIA PACIFIC: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2024–2031 (USD MILLION) 183
TABLE 185 LATIN AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2024–2031 (USD MILLION) 183
TABLE 186 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY COUNTRY, 2024–2031 (USD MILLION) 183
TABLE 187 KEY PRODUCTS IN LABORATORY TESTS MARKET 184
TABLE 188 URINALYSIS MARKET FOR LABORATORY TESTS, BY REGION, 2024–2031 (USD MILLION) 184
TABLE 189 NORTH AMERICA: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2024–2031 (USD MILLION) 185
TABLE 190 EUROPE: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2024–2031 (USD MILLION) 185
TABLE 191 ASIA PACIFIC: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2024–2031 (USD MILLION) 186
TABLE 192 LATIN AMERICA: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2024–2031 (USD MILLION) 186
TABLE 193 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2024–2031 (USD MILLION) 187
TABLE 194 KEY PRODUCTS IN POC TESTS MARKET 187
TABLE 195 URINALYSIS MARKET FOR POC TESTS, BY REGION, 2024–2031 (USD MILLION) 188
TABLE 196 NORTH AMERICA: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2024–2031 (USD MILLION) 188
TABLE 197 EUROPE: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2024–2031 (USD MILLION) 188
TABLE 198 ASIA PACIFIC: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2024–2031 (USD MILLION) 189
TABLE 199 LATIN AMERICA: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2024–2031 (USD MILLION) 189
TABLE 200 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR POC TESTS, BY COUNTRY, 2024–2031 (USD MILLION) 189
TABLE 201 URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY REGION, 2024–2031 (USD MILLION) 190
TABLE 202 NORTH AMERICA: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 190
TABLE 203 EUROPE: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 191
TABLE 204 ASIA PACIFIC: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 191
TABLE 205 LATIN AMERICA: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 192
TABLE 206 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 192
TABLE 207 URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 194
TABLE 208 URINALYSIS MARKET FOR BIOCHEMICAL ASSAY, BY REGION, 2024–2031 (USD MILLION) 195
TABLE 209 NORTH AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL ASSAY, BY COUNTRY, 2024–2031 (USD MILLION) 195
TABLE 210 EUROPE: URINALYSIS MARKET FOR BIOCHEMICAL ASSAY, BY COUNTRY, 2024–2031 (USD MILLION) 195
TABLE 211 ASIA PACIFIC: URINALYSIS MARKET FOR BIOCHEMICAL ASSAY, BY COUNTRY, 2024–2031 (USD MILLION) 196
TABLE 212 LATIN AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL ASSAY, BY COUNTRY, 2024–2031 (USD MILLION) 196
TABLE 213 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR BIOCHEMICAL ASSAY, BY COUNTRY, 2024–2031 (USD MILLION) 196
TABLE 214 URINALYSIS MARKET FOR FLOW CYTOMETRY, BY REGION, 2024–2031 (USD MILLION) 197
TABLE 215 NORTH AMERICA: URINALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2024–2031 (USD MILLION) 197
TABLE 216 EUROPE: URINALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2024–2031 (USD MILLION) 198
TABLE 217 ASIA PACIFIC: URINALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2024–2031 (USD MILLION) 198
TABLE 218 LATIN AMERICA: URINALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2024–2031 (USD MILLION) 199
TABLE 219 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2024–2031 (USD MILLION) 199
TABLE 220 URINALYSIS MARKET FOR DIGITAL MICROSCOPY, BY REGION, 2024–2031 (USD MILLION) 200
TABLE 221 NORTH AMERICA: URINALYSIS MARKET FOR DIGITAL MICROSCOPY, BY COUNTRY, 2024–2031 (USD MILLION) 200
TABLE 222 EUROPE: URINALYSIS MARKET FOR DIGITAL MICROSCOPY, BY COUNTRY, 2024–2031 (USD MILLION) 200
TABLE 223 ASIA PACIFIC: URINALYSIS MARKET FOR DIGITAL MICROSCOPY, BY COUNTRY, 2024–2031 (USD MILLION) 201
TABLE 224 LATIN AMERICA: URINALYSIS MARKET FOR DIGITAL MICROSCOPY, BY COUNTRY, 2024–2031 (USD MILLION) 201
TABLE 225 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR DIGITAL MICROSCOPY, BY COUNTRY, 2024–2031 (USD MILLION) 201
TABLE 226 URINALYSIS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2024–2031 (USD MILLION) 202
TABLE 227 NORTH AMERICA: URINALYSIS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION) 202
TABLE 228 EUROPE: URINALYSIS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION) 203
TABLE 229 ASIA PACIFIC: URINALYSIS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION) 203
TABLE 230 LATIN AMERICA: URINALYSIS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION) 204
TABLE 231 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION) 204
TABLE 232 URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 206
TABLE 233 URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2024–2031 (USD MILLION) 207
TABLE 234 NORTH AMERICA: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 207
TABLE 235 EUROPE: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 208
TABLE 236 ASIA PACIFIC: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 208
TABLE 237 LATIN AMERICA: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 209
TABLE 238 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 209
TABLE 239 URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2024–2031 (USD MILLION) 210
TABLE 240 NORTH AMERICA: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION) 210
TABLE 241 EUROPE: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION) 211
TABLE 242 ASIA PACIFIC: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION) 211
TABLE 243 LATIN AMERICA: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION) 212
TABLE 244 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION) 212
TABLE 245 URINALYSIS MARKET FOR HOME CARE SETTINGS, BY REGION, 2024–2031 (USD MILLION) 213
TABLE 246 NORTH AMERICA: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION) 213
TABLE 247 EUROPE: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION) 214
TABLE 248 ASIA PACIFIC: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION) 214
TABLE 249 LATIN AMERICA: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION) 215
TABLE 250 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION) 215
TABLE 251 URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 216
TABLE 252 NORTH AMERICA: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 216
TABLE 253 EUROPE: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 217
TABLE 254 ASIA PACIFIC: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 217
TABLE 255 LATIN AMERICA: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 218
TABLE 256 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 218
TABLE 257 URINALYSIS MARKET, BY REGION, 2024–2031 (USD MILLION) 220
TABLE 258 NORTH AMERICA: MACROECONOMIC INDICATORS 222
TABLE 259 NORTH AMERICA: URINALYSIS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 222
TABLE 260 NORTH AMERICA: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 222
TABLE 261 NORTH AMERICA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 223
TABLE 262 NORTH AMERICA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 223
TABLE 263 NORTH AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 223
TABLE 264 NORTH AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 224
TABLE 265 NORTH AMERICA: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 224
TABLE 266 NORTH AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION) 224
TABLE 267 NORTH AMERICA: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 225
TABLE 268 NORTH AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION) 225
TABLE 269 NORTH AMERICA: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 225
TABLE 270 NORTH AMERICA: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 226
TABLE 271 US LABORATORY-BASED URINALYSIS TEST VOLUME, 2024–2031 (IN MN) 227
TABLE 272 US: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 227
TABLE 273 US: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 227
TABLE 274 US: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 228
TABLE 275 US: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 228
TABLE 276 US: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 228
TABLE 277 US: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 229
TABLE 278 US: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION) 229
TABLE 279 US: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 229
TABLE 280 US: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION) 230
TABLE 281 US: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 230
TABLE 282 US: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 230
TABLE 283 CANADA: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 231
TABLE 284 CANADA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 232
TABLE 285 CANADA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 232
TABLE 286 CANADA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 232
TABLE 287 CANADA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 233
TABLE 288 CANADA: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 233
TABLE 289 CANADA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION) 233
TABLE 290 CANADA: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 234
TABLE 291 CANADA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION) 234
TABLE 292 CANADA: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 234
TABLE 293 CANADA: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 235
TABLE 294 MACROECONOMIC INDICATORS FOR EUROPE 236
TABLE 295 EUROPE: URINALYSIS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 236
TABLE 296 EUROPE: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 237
TABLE 297 EUROPE: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 237
TABLE 298 EUROPE: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 237
TABLE 299 EUROPE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 238
TABLE 300 EUROPE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 238
TABLE 301 EUROPE: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 238
TABLE 302 EUROPE: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION) 239
TABLE 303 EUROPE: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 239
TABLE 304 EUROPE: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION) 239
TABLE 305 EUROPE: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 240
TABLE 306 EUROPE: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 240
TABLE 307 GERMANY: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 241
TABLE 308 GERMANY: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 241
TABLE 309 GERMANY: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 242
TABLE 310 GERMANY: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 242
TABLE 311 GERMANY: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 242
TABLE 312 GERMANY: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 243
TABLE 313 GERMANY: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION) 243
TABLE 314 GERMANY: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 243
TABLE 315 GERMANY: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION) 244
TABLE 316 GERMANY: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 244
TABLE 317 GERMANY: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 244
TABLE 318 UK: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 245
TABLE 319 UK: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 246
TABLE 320 UK: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 246
TABLE 321 UK: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 246
TABLE 322 UK: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 247
TABLE 323 UK: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 247
TABLE 324 UK: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION) 247
TABLE 325 UK: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 248
TABLE 326 UK: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION) 248
TABLE 327 UK: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 248
TABLE 328 UK: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 249
TABLE 329 FRANCE: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 250
TABLE 330 FRANCE: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 250
TABLE 331 FRANCE: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 250
TABLE 332 FRANCE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 251
TABLE 333 FRANCE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 251
TABLE 334 FRANCE: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 251
TABLE 335 FRANCE: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION) 252
TABLE 336 FRANCE: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 252
TABLE 337 FRANCE: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION) 252
TABLE 338 FRANCE: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 253
TABLE 339 FRANCE: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 253
TABLE 340 ITALY: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 254
TABLE 341 ITALY: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 254
TABLE 342 ITALY: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 255
TABLE 343 ITALY: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 255
TABLE 344 ITALY: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 255
TABLE 345 ITALY: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 256
TABLE 346 ITALY: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION) 256
TABLE 347 ITALY: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 256
TABLE 348 ITALY: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION) 257
TABLE 349 ITALY: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 257
TABLE 350 ITALY: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 257
TABLE 351 SPAIN: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 258
TABLE 352 SPAIN: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 258
TABLE 353 SPAIN: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 259
TABLE 354 SPAIN: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 259
TABLE 355 SPAIN: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 259
TABLE 356 SPAIN: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 260
TABLE 357 SPAIN: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION) 260
TABLE 358 SPAIN: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 260
TABLE 359 SPAIN: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION) 261
TABLE 360 SPAIN: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 261
TABLE 361 SPAIN: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 261
TABLE 362 REST OF EUROPE: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 262
TABLE 363 REST OF EUROPE: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 263
TABLE 364 REST OF EUROPE: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 263
TABLE 365 REST OF EUROPE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 263
TABLE 366 REST OF EUROPE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 264
TABLE 367 REST OF EUROPE: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 264
TABLE 368 REST OF EUROPE: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION) 264
TABLE 369 REST OF EUROPE: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 265
TABLE 370 REST OF EUROPE: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION) 265
TABLE 371 REST OF EUROPE: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 265
TABLE 372 REST OF EUROPE: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 266
TABLE 373 MACROECONOMIC INDICATORS FOR ASIA PACIFIC 267
TABLE 374 ASIA PACIFIC: URINALYSIS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 268
TABLE 375 ASIA PACIFIC: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 268
TABLE 376 ASIA PACIFIC: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 268
TABLE 377 ASIA PACIFIC: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 269
TABLE 378 ASIA PACIFIC: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 269
TABLE 379 ASIA PACIFIC: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 269
TABLE 380 ASIA PACIFIC: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 270
TABLE 381 ASIA PACIFIC: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION) 270
TABLE 382 ASIA PACIFIC: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 270
TABLE 383 ASIA PACIFIC: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION) 271
TABLE 384 ASIA PACIFIC: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 271
TABLE 385 ASIA PACIFIC: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 271
TABLE 386 CHINA: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 273
TABLE 387 CHINA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 273
TABLE 388 CHINA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 273
TABLE 389 CHINA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 274
TABLE 390 CHINA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 274
TABLE 391 CHINA: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 274
TABLE 392 CHINA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION) 275
TABLE 393 CHINA: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 275
TABLE 394 CHINA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION) 275
TABLE 395 CHINA: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 276
TABLE 396 CHINA: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 276
TABLE 397 JAPAN: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 277
TABLE 398 JAPAN: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 278
TABLE 399 JAPAN: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 278
TABLE 400 JAPAN: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 278
TABLE 401 JAPAN: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 279
TABLE 402 JAPAN: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 279
TABLE 403 JAPAN: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION) 279
TABLE 404 JAPAN: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 280
TABLE 405 JAPAN: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION) 280
TABLE 406 JAPAN: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 280
TABLE 407 JAPAN: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 281
TABLE 408 INDIA: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 281
TABLE 409 INDIA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 282
TABLE 410 INDIA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 282
TABLE 411 INDIA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 282
TABLE 412 INDIA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 283
TABLE 413 INDIA: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 283
TABLE 414 INDIA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION) 283
TABLE 415 INDIA: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 284
TABLE 416 INDIA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION) 284
TABLE 417 INDIA: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 284
TABLE 418 INDIA: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 285
TABLE 419 AUSTRALIA: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 285
TABLE 420 AUSTRALIA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 286
TABLE 421 AUSTRALIA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 286
TABLE 422 AUSTRALIA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 286
TABLE 423 AUSTRALIA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 287
TABLE 424 AUSTRALIA: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 287
TABLE 425 AUSTRALIA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION) 287
TABLE 426 AUSTRALIA: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 288
TABLE 427 AUSTRALIA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION) 288
TABLE 428 AUSTRALIA: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 288
TABLE 429 AUSTRALIA: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 289
TABLE 430 SOUTH KOREA: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 289
TABLE 431 SOUTH KOREA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 290
TABLE 432 SOUTH KOREA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 290
TABLE 433 SOUTH KOREA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 290
TABLE 434 SOUTH KOREA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 291
TABLE 435 SOUTH KOREA: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 291
TABLE 436 SOUTH KOREA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION) 291
TABLE 437 SOUTH KOREA: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 292
TABLE 438 SOUTH KOREA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION) 292
TABLE 439 SOUTH KOREA: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 292
TABLE 440 SOUTH KOREA: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 293
TABLE 441 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 294
TABLE 442 REST OF ASIA PACIFIC: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 294
TABLE 443 REST OF ASIA PACIFIC: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 295
TABLE 444 REST OF ASIA PACIFIC: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 295
TABLE 445 REST OF ASIA PACIFIC: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 295
TABLE 446 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 296
TABLE 447 REST OF ASIA PACIFIC: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION) 296
TABLE 448 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 296
TABLE 449 REST OF ASIA PACIFIC: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION) 297
TABLE 450 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 297
TABLE 451 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 297
TABLE 452 MACROECONOMIC INDICATORS FOR LATIN AMERICA 298
TABLE 453 LATIN AMERICA: URINALYSIS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 299
TABLE 454 LATIN AMERICA: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 299
TABLE 455 LATIN AMERICA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 299
TABLE 456 LATIN AMERICA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 300
TABLE 457 LATIN AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 300
TABLE 458 LATIN AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 300
TABLE 459 LATIN AMERICA: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 301
TABLE 460 LATIN AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION) 301
TABLE 461 LATIN AMERICA: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 301
TABLE 462 LATIN AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION) 302
TABLE 463 LATIN AMERICA: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 302
TABLE 464 LATIN AMERICA: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 302
TABLE 465 BRAZIL: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 303
TABLE 466 BRAZIL: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 303
TABLE 467 BRAZIL: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 304
TABLE 468 BRAZIL: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 304
TABLE 469 BRAZIL: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 304
TABLE 470 BRAZIL: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 305
TABLE 471 BRAZIL: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION) 305
TABLE 472 BRAZIL: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 305
TABLE 473 BRAZIL: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION) 306
TABLE 474 BRAZIL: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 306
TABLE 475 BRAZIL: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 306
TABLE 476 MEXICO: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 307
TABLE 477 MEXICO: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 308
TABLE 478 MEXICO: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 308
TABLE 479 MEXICO: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 308
TABLE 480 MEXICO: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 309
TABLE 481 MEXICO: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 309
TABLE 482 MEXICO: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION) 309
TABLE 483 MEXICO: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 310
TABLE 484 MEXICO: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION) 310
TABLE 485 MEXICO: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 310
TABLE 486 MEXICO: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 311
TABLE 487 REST OF LATIN AMERICA: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 312
TABLE 488 REST OF LATIN AMERICA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 312
TABLE 489 REST OF LATIN AMERICA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 312
TABLE 490 REST OF LATIN AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 313
TABLE 491 REST OF LATIN AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 313
TABLE 492 REST OF LATIN AMERICA: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 313
TABLE 493 REST OF LATIN AMERICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION) 314
TABLE 494 REST OF LATIN AMERICA: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 314
TABLE 495 REST OF LATIN AMERICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION) 314
TABLE 496 REST OF LATIN AMERICA: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 315
TABLE 497 REST OF LATIN AMERICA: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 315
TABLE 498 MACROECONOMIC INDICATORS FOR MIDDLE EAST & AFRICA 316
TABLE 499 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 316
TABLE 500 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 316
TABLE 501 MIDDLE EAST & AFRICA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 317
TABLE 502 MIDDLE EAST & AFRICA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 317
TABLE 503 MIDDLE EAST & AFRICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 317
TABLE 504 MIDDLE EAST & AFRICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 318
TABLE 505 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 318
TABLE 506 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION) 318
TABLE 507 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 319
TABLE 508 MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION) 319
TABLE 509 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 319
TABLE 510 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 320
TABLE 511 UAE: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 320
TABLE 512 UAE: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 321
TABLE 513 UAE: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 321
TABLE 514 UAE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 321
TABLE 515 UAE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 322
TABLE 516 UAE: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 322
TABLE 517 UAE: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION) 322
TABLE 518 UAE: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 323
TABLE 519 UAE: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION) 323
TABLE 520 UAE: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 323
TABLE 521 UAE: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 324
TABLE 522 SAUDI ARABIA: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 324
TABLE 523 SAUDI ARABIA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 325
TABLE 524 SAUDI ARABIA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 325
TABLE 525 SAUDI ARABIA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 325
TABLE 526 SAUDI ARABIA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 326
TABLE 527 SAUDI ARABIA: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 326
TABLE 528 SAUDI ARABIA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION) 326
TABLE 529 SAUDI ARABIA: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 327
TABLE 530 SAUDI ARABIA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION) 327
TABLE 531 SAUDI ARABIA: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 327
TABLE 532 SAUDI ARABIA: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 328
TABLE 533 REST OF THE MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 328
TABLE 534 REST OF THE MIDDLE EAST & AFRICA: URINALYSIS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 329
TABLE 535 REST OF THE MIDDLE EAST & AFRICA: URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 329
TABLE 536 EST OF THE MIDDLE EAST & AFRICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 329
TABLE 537 REST OF THE MIDDLE EAST & AFRICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 330
TABLE 538 REST OF THE MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY TEST TYPE, 2024–2031 (USD MILLION) 330
TABLE 539 REST OF THE MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2024–2031 (USD MILLION) 330
TABLE 540 REST OF THE MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 331
TABLE 541 REST OF THE MIDDLE EAST & AFRICA: URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2024–2031 (USD MILLION) 331
TABLE 542 REST OF THE MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 331
TABLE 543 REST OF THE MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY END USER, 2024–2031 (USD MILLION) 332
TABLE 544 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN URINALYSIS MARKET, JANUARY 2023−JULY 2026 334
TABLE 545 URINALYSIS MARKET: DEGREE OF COMPETITION 337
TABLE 546 URINALYSIS MARKET: REGION FOOTPRINT 340
TABLE 547 URINALYSIS MARKET: PRODUCT FOOTPRINT 341
TABLE 548 URINALYSIS MARKET: APPLICATION FOOTPRINT 341
TABLE 549 URINALYSIS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 344
TABLE 550 URINALYSIS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, BY PRODUCT AND APPLICATION 345
TABLE 551 URINALYSIS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, BY REGION 345
TABLE 552 URINALYSIS MARKET: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2023– JULY 2026 348
TABLE 553 URINALYSIS MARKET: DEALS, JANUARY 2023– JULY 2026 348
TABLE 554 URINALYSIS MARKET: EXPANSION, JANUARY 2023– JULY 2026 350
TABLE 555 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 352
TABLE 556 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED 353
TABLE 557 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026 354
TABLE 558 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2023–JULY 2026 355
TABLE 559 SIEMENS HEALTHINEERS AG: EXPANSIONS, JANUARY 2023–JULY 2026 356
TABLE 560 F. HOFFMANN-LA ROCHE LTD: COMPANY OVERVIEW 358
TABLE 561 F. HOFFMANN-LA ROCHE LTD: PRODUCTS OFFERED 359
TABLE 562 SYSMEX CORPORATION: COMPANY OVERVIEW 361
TABLE 563 SYSMEX CORPORATION: PRODUCTS OFFERED 362
TABLE 564 SYSMEX CORPORATION: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026 363
TABLE 565 SYSMEX CORPORATION: EXPANSIONS, JANUARY 2023–JULY 2026 363
TABLE 566 DANAHER CORPORATION: COMPANY OVERVIEW 365
TABLE 567 DANAHER CORPORATION: PRODUCTS OFFERED 366
TABLE 568 DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026 367
TABLE 569 DANAHER CORPORATION: DEALS, JANUARY 2023–JULY 2026 367
TABLE 570 ABBOTT: COMPANY OVERVIEW 369
TABLE 571 ABBOTT: PRODUCTS OFFERED 370
TABLE 572 CARDINAL HEALTH, INC.: COMPANY OVERVIEW 373
TABLE 573 CARDINAL HEALTH, INC.: PRODUCTS OFFERED 374
TABLE 574 CARDINAL HEALTH, INC.: EXPANSIONS, JANUARY 2023–JULY 2026 375
TABLE 575 WATERS CORPORATION: COMPANY OVERVIEW 376
TABLE 576 WATERS CORPORATION: PRODUCTS OFFERED 377
TABLE 577 WATERS CORPORATION: DEALS, JANUARY 2023–JULY 2026 378
TABLE 578 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 379
TABLE 579 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 380
TABLE 580 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 381
TABLE 581 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED 382
TABLE 582 QUIDELORTHO CORPORATION: COMPANY OVERVIEW 383
TABLE 583 QUIDELORTHO CORPORATION: PRODUCTS OFFERED 384
TABLE 584 URINALYSIS MARKET: RISK ASSESSMENT 415
FIGURE 1 URINALYSIS MARKET SEGMENTATION 40
FIGURE 2 KEY INSIGHTS AND MARKET HIGHLIGHTS 44
FIGURE 3 GLOBAL URINALYSIS MARKET, 2024–2031 45
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN
URINALYSIS MARKET, 2023–2025 45
FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF URINALYSIS MARKET 46
FIGURE 6 HIGH-GROWTH SEGMENTS AND EMERGING
FRONTIERS IN URINALYSIS MARKET, 2025 47
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 48
FIGURE 8 INCREASING PREVALENCE OF CHRONIC DISEASES TO SUPPORT MARKET GROWTH 49
FIGURE 9 CONSUMABLES SEGMENT TO DOMINATE URINALYSIS MARKET 49
FIGURE 10 BIOCHEMICAL TESTS SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 50
FIGURE 11 DISEASE SCREENING SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 50
FIGURE 12 BIOCHEMICAL ASSAY SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 51
FIGURE 13 DIAGNOSTIC LABORATORIES SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 51
FIGURE 14 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 52
FIGURE 15 URINALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 53
FIGURE 16 URINALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS 65
FIGURE 17 URINALYSIS MARKET: SUPPLY CHAIN ANALYSIS 71
FIGURE 18 URINALYSIS MARKET: VALUE CHAIN ANALYSIS 72
FIGURE 19 URINALYSIS MARKET: ECOSYSTEM ANALYSIS 73
FIGURE 20 URINALYSIS MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS 79
FIGURE 21 NUMBER OF DEALS & FUNDING ACTIVITIES IN URINALYSIS MARKET 80
FIGURE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT 84
FIGURE 23 KEY BUYING CRITERIA, BY PRODUCT 85
FIGURE 24 PATENT ANALYSIS FOR URINALYSIS, JANUARY 2016–DECEMBER 2025 100
FIGURE 25 MARKET POTENTIAL OF AI IN URINALYSIS MARKET 104
FIGURE 26 NORTH AMERICA: URINALYSIS MARKET SNAPSHOT 221
FIGURE 27 ASIA PACIFIC: URINALYSIS MARKET SNAPSHOT 267
FIGURE 28 REVENUE ANALYSIS OF KEY PLAYERS IN URINALYSIS MARKET, 2023–2025 (USD MILLION) 335
FIGURE 29 URINALYSIS MARKET SHARE ANALYSIS, 2025 (GLOBAL) 336
FIGURE 30 URINALYSIS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 339
FIGURE 31 URINALYSIS MARKET: COMPANY FOOTPRINT 340
FIGURE 32 URINALYSIS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 343
FIGURE 33 EV/EBITDA OF KEY VENDORS 346
FIGURE 34 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 346
FIGURE 35 URINALYSIS MARKET: BRAND/PRODUCT COMPARISON FOR URINE ANALYZERS 347
FIGURE 36 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2025) 353
FIGURE 37 F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT (2025) 359
FIGURE 38 SYSMEX CORPORATION: COMPANY SNAPSHOT (2025) 362
FIGURE 39 DANAHER CORPORATION: COMPANY SNAPSHOT (2025) 366
FIGURE 40 ABBOTT: COMPANY SNAPSHOT (2025) 370
FIGURE 41 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2025) 374
FIGURE 42 WATERS CORPORATION: COMPANY SNAPSHOT (2025) 377
FIGURE 43 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025) 380
FIGURE 44 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2025) 382
FIGURE 45 QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2025) 384
FIGURE 46 URINALYSIS MARKET: RESEARCH DESIGN METHODOLOGY 403
FIGURE 47 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 408
FIGURE 48 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 409
FIGURE 49 URINALYSIS MARKET: TOP-DOWN APPROACH 410
FIGURE 50 DATA TRIANGULATION METHODOLOGY 412
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們